Is GoHealth Stock a Good Investment?

GoHealth Investment Advice

  GOCO
To provide specific investment advice or recommendations on GoHealth stock, we recommend investors consider the following general factors when evaluating GoHealth. This will help you to make an informed decision on whether to include GoHealth in one of your diversified portfolios:
  • Examine GoHealth's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research GoHealth's leadership team and their track record. Good management can help GoHealth navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Property & Casualty Insurance space and any emerging trends that could impact GoHealth's business and its evolving consumer preferences.
  • Compare GoHealth's performance and market position to its competitors. Analyze how GoHealth is positioned in terms of product offerings, innovation, and market share.
  • Check if GoHealth pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about GoHealth's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in GoHealth stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if GoHealth is a good investment.
 
Sell
 
Buy
Cautious Hold
Our advice tool can cross-verify current analyst consensus on GoHealth and to analyze the company potential to grow for the next few years. To make sure GoHealth is not overpriced, please check out all GoHealth fundamentals, including its total debt, beta, and the relationship between the gross profit and short ratio . Given that GoHealth has a number of shares shorted of 204.15 K, we strongly advise you to confirm GoHealth market performance and probability of bankruptcy to ensure the company can sustain itself for the next few years given your regular risk tolerance and investing horizon.

Market Performance

OKDetails

Volatility

Somewhat reliableDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine GoHealth Stock

Researching GoHealth's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 15.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.55. Some equities with similar Price to Book (P/B) outperform the market in the long run. GoHealth recorded a loss per share of 3.29. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 18th of November 2022.
To determine if GoHealth is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GoHealth's research are outlined below:
GoHealth had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 734.67 M. Net Loss for the year was (63.26 M) with profit before overhead, payroll, taxes, and interest of 444 M.
About 15.0% of the company shares are held by company insiders
Latest headline from news.google.com: GoHealth Reports Q3 Loss, Tops Revenue Estimates - MSN

GoHealth Quarterly Liabilities And Stockholders Equity

1.34 Billion

GoHealth uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in GoHealth. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GoHealth's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
21st of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact GoHealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises GoHealth's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-05-12
2021-03-31-0.15-0.3-0.15100 
2023-11-09
2023-09-30-2.9-2.610.2910 
2020-08-19
2020-06-30-0.6-0.9-0.350 
2023-08-10
2023-06-30-2.92-3.27-0.3511 
2022-05-10
2022-03-31-1.33-1.8-0.4735 
2023-05-08
2023-03-31-1.96-1.120.8442 
2022-11-10
2022-09-30-4.3-3.31.023 
2022-08-15
2022-06-30-3.38-2.251.1333 

Know GoHealth's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as GoHealth is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GoHealth backward and forwards among themselves. GoHealth's institutional investor refers to the entity that pools money to purchase GoHealth's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Renaissance Technologies Corp2024-09-30
21.6 K
Bridgeway Capital Management, Llc2024-06-30
21 K
Empowered Funds, Llc2024-06-30
21 K
Charles Schwab Investment Management Inc2024-09-30
15.4 K
Susquehanna International Group, Llp2024-06-30
14.8 K
Citadel Advisors Llc2024-06-30
13.3 K
Bank Of New York Mellon Corp2024-06-30
13 K
Amvescap Plc.2024-06-30
12.5 K
Bank Of America Corp2024-06-30
6.2 K
Centerbridge Partners, L.p.2024-06-30
4.2 M
Blackrock Inc2024-06-30
294.6 K
Note, although GoHealth's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

GoHealth's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 263.41 M.

Market Cap

438.86 Million

GoHealth's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed(0.07)(0.07)
Return On Assets(0.04)(0.04)
Return On Equity(0.27)(0.29)
The company has Profit Margin (PM) of (0.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.35) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.35.
Determining GoHealth's profitability involves analyzing its financial statements and using various financial metrics to determine if GoHealth is a good buy. For example, gross profit margin measures GoHealth's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GoHealth's profitability and make more informed investment decisions.

Evaluate GoHealth's management efficiency

GoHealth has return on total asset (ROA) of (0.0276) % which means that it has lost $0.0276 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1588) %, meaning that it created substantial loss on money invested by shareholders. GoHealth's management efficiency ratios could be used to measure how well GoHealth manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to drop to -0.06. In addition to that, Return On Capital Employed is likely to grow to -0.07. At this time, GoHealth's Total Assets are very stable compared to the past year. As of the 22nd of November 2024, Non Current Assets Total is likely to grow to about 1.3 B, while Net Tangible Assets are likely to drop (220.4 M).
Last ReportedProjected for Next Year
Book Value Per Share 43.66  41.47 
Tangible Book Value Per Share 0.98  0.93 
Enterprise Value Over EBITDA 25.95  47.61 
Price Book Value Ratio 0.54  0.56 
Enterprise Value Multiple 25.95  47.61 
Price Fair Value 0.54  0.56 
Enterprise Value1.2 B1.1 B
GoHealth showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta
1.651

Basic technical analysis of GoHealth Stock

As of the 22nd of November, GoHealth retains the Risk Adjusted Performance of 0.1193, market risk adjusted performance of 1.43, and Semi Deviation of 3.66. GoHealth technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

GoHealth's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GoHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on GoHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GoHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

GoHealth's Outstanding Corporate Bonds

GoHealth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GoHealth uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GoHealth bonds can be classified according to their maturity, which is the date when GoHealth has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand GoHealth's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing GoHealth's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider GoHealth's intraday indicators

GoHealth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GoHealth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

GoHealth Corporate Filings

8K
7th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
4th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
23rd of October 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
21st of June 2024
An amendment to a previously filed Form 8-K
ViewVerify
GoHealth time-series forecasting models is one of many GoHealth's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GoHealth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

GoHealth Stock media impact

Far too much social signal, news, headlines, and media speculation about GoHealth that are available to investors today. That information is available publicly through GoHealth media outlets and privately through word of mouth or via GoHealth internal channels. However, regardless of the origin, that massive amount of GoHealth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of GoHealth news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of GoHealth relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to GoHealth's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive GoHealth alpha.

GoHealth Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards GoHealth can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

GoHealth Corporate Management

Michael KelleyChief InsightsProfile
Melissa BalsanChief OfficerProfile
Michael HargisChief OfficerProfile
Shane CruzChief OfficerProfile
Blair KesslerChief OfficerProfile
Jason SchulzExecutive OfficerProfile
Stephen MoffatChief OfficerProfile
When determining whether GoHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GoHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Gohealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Gohealth Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.241
Earnings Share
(3.29)
Revenue Per Share
69.776
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.03)
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between GoHealth's value and its price, as these two are different measures arrived at by various means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.